• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[白喉:关于一场流行病]

[Diphtheria: apropos of an epidemic].

作者信息

Bricaire F

出版信息

Presse Med. 1996;25(8):327-9.

PMID:8685176
Abstract

Since Ramon developed the anti-diphtheria anatoxin in 1924 widespread vaccination has almost eliminated diphtheria, but since the acquired immunity is anatoxic and not anti-bacterial, carriage of the causal agent Corynebacterium diphteriae remains possible. In 1990, 1214 declared cases of diphtheria inaugurated an epidemic which spread through Russia, Ukraine and neighboring countries and even reached a few subjects in Europe and North America. Mortality in Russia was 10.15 per 100000 cases in 1993. Higher rates were observed in children. The question is raised as to the level of protection in Western countries despite generalized vaccination programs. In France, a recent survey showed that only 49.3% of the 1004 subjects evaluated had complete protection and 20.4% had no protection at all. While 95% of young adults in the 15 to 24 age range were protected, the rate of protection was below one-third in subjects over 65. These results emphasize the importance of anti-diphtheria vaccination programs and continued surveillance in adult populations. Current French legislation requires vaccination before the age of 18 months but without any requirement for re-vaccination in adults. The current situation clearly demonstrates that the risk of a diphtheria epidemic still exists, even in our Western countries. To completely protect the population, the present vaccination policy should include re-vaccinations of the adult population every 10 years, as for tetanus. Use of a preparation containing a reduced dose of vaccine, given with the tetanus and polio booster shots, is to be recommended. Re-vaccination with DT or the reduced dose dT would also be indicated after injury instead of tetanus alone. Surveillance and typing of C. diphteriae strains isolated from clinical cases should also be maintained.

摘要

自1924年拉蒙研制出抗白喉抗毒素以来,广泛接种疫苗几乎已消除了白喉,但由于获得的免疫力是抗毒素性的而非抗细菌性的,致病因子白喉棒状杆菌的携带仍有可能。1990年,1214例申报的白喉病例引发了一场疫情,疫情蔓延至俄罗斯、乌克兰及周边国家,甚至波及了欧洲和北美的一些人。1993年俄罗斯的死亡率为每10万例10.15人。儿童中的死亡率更高。尽管有普遍的疫苗接种计划,但西方国家的保护水平仍受到质疑。在法国,最近一项调查显示,在接受评估的1004名受试者中,只有49.3%有完全的保护,20.4%根本没有保护。虽然15至24岁年龄组的年轻成年人中有95%受到了保护,但65岁以上受试者的保护率低于三分之一。这些结果强调了抗白喉疫苗接种计划以及对成年人群持续监测的重要性。法国现行法律要求在18个月龄前接种疫苗,但对成年人再次接种没有任何要求。目前的情况清楚地表明,即使在我们西方国家,白喉疫情的风险仍然存在。为了全面保护人群,目前的疫苗接种政策应包括每10年对成年人群进行一次再次接种,如同破伤风疫苗那样。建议使用含有减量疫苗的制剂,与破伤风和脊髓灰质炎加强针一起接种。受伤后也应接种白喉破伤风联合疫苗(DT)或减量的白喉破伤风疫苗(dT),而不仅仅是破伤风疫苗。还应持续监测从临床病例中分离出的白喉棒状杆菌菌株并进行分型。

相似文献

1
[Diphtheria: apropos of an epidemic].[白喉:关于一场流行病]
Presse Med. 1996;25(8):327-9.
2
Risk of diphtheria among schoolchildren in the Russian Federation in relation to time since last vaccination.俄罗斯联邦学童中白喉风险与上次接种疫苗后的时间关系。
Lancet. 1999 Jan 30;353(9150):355-8. doi: 10.1016/S0140-6736(98)03488-6.
3
Contraindications to vaccination in the Russian Federation.俄罗斯联邦疫苗接种的禁忌症。
J Infect Dis. 2000 Feb;181 Suppl 1:S228-31. doi: 10.1086/315567.
4
[Diphtheria booster immunization for adults].成人白喉加强免疫
Dtsch Med Wochenschr. 1997 Mar 7;122(10):281-6. doi: 10.1055/s-2008-1047609.
5
[The return of diphtheria in Europe. Is the French population protected?].
Bull Acad Natl Med. 1997 Jan;181(1):93-100; discussion 100-2.
6
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).预防青少年破伤风、白喉和百日咳:破伤风类毒素、白喉类毒素含量降低的无细胞百日咳疫苗的使用——免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.
7
Epidemic diphtheria in Belarus, 1992-1997.1992 - 1997年白俄罗斯的流行性白喉
J Infect Dis. 2000 Feb;181 Suppl 1:S41-6. doi: 10.1086/315537.
8
[Antidiphtheria immunity in children after immunization with adsorbed DPT vaccine and ADPT-M toxoid].
Zh Mikrobiol Epidemiol Immunobiol. 2006 Jan-Feb(1):67-8.
9
Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.Tdap5 疫苗(Covaxis):作为一种单剂疫苗,用于预防儿童(4 岁)、青少年和成人破伤风、白喉和百日咳的用途综述。
BioDrugs. 2010 Dec 1;24(6):387-406. doi: 10.2165/11206000-000000000-00000.
10
Implications of the diphtheria epidemic in the Former Soviet Union for immunization programs.前苏联白喉疫情对免疫规划的影响。
J Infect Dis. 2000 Feb;181 Suppl 1:S244-8. doi: 10.1086/315570.

引用本文的文献

1
Corynebacterium diphtheriae: identification and characterization of a channel-forming protein in the cell wall.白喉棒状杆菌:细胞壁中一种形成通道蛋白的鉴定与表征
J Bacteriol. 2007 Nov;189(21):7709-19. doi: 10.1128/JB.00864-07. Epub 2007 Aug 24.
2
Clinical microbiology of coryneform bacteria.棒状杆菌的临床微生物学
Clin Microbiol Rev. 1997 Jan;10(1):125-59. doi: 10.1128/CMR.10.1.125.